These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridostigmine by lowering serum free fatty acid in normal and obese subjects. Lee EJ; Nam SY; Kim KR; Lee HC; Cho JH; Nam MS; Song YD; Lim SK; Huh KB J Clin Endocrinol Metab; 1995 Aug; 80(8):2495-8. PubMed ID: 7629249 [TBL] [Abstract][Full Text] [Related]
63. [Response of growth hormone (HGH) to L-dopa, L-arginine and their combination in normal individuals]. Hernández Armas J; González García C; Rodríguez I Med Clin (Barc); 1982 Nov 1-15; 79(8):365-9. PubMed ID: 6757593 [No Abstract] [Full Text] [Related]
64. [Effect of L-dopa and propranolol administration on GH secretion in essential obesity in women]. Cabezas-Cerrato J; Mur AL; Aranguren LV; Vila T; Fernández-Cruz A Rev Clin Esp; 1975 Jun; 137(6):497-502. PubMed ID: 1162133 [No Abstract] [Full Text] [Related]
65. Evidence for a direct pituitary inhibition by free fatty acids of in vivo growth hormone responses to growth hormone-releasing hormone in the rat. Alvarez CV; Mallo F; Burguera B; Cacicedo L; Dieguez C; Casanueva FF Neuroendocrinology; 1991 Feb; 53(2):185-9. PubMed ID: 1673023 [TBL] [Abstract][Full Text] [Related]
66. Human growth hormone and placental lactogen levels in midpregnancy and late postpartum. Spellacy WN; Buhi WC; Birk SA Obstet Gynecol; 1970 Aug; 36(2):238-43. PubMed ID: 5428490 [No Abstract] [Full Text] [Related]
67. Inhibition of endogenous growth hormone secretion by exogenous growth hormone infusion in the rhesus monkey. Sakuma M; Knobil E Endocrinology; 1970 Apr; 86(4):890-4. PubMed ID: 4984004 [No Abstract] [Full Text] [Related]
69. [Effects of oral administration of L-dopa on the secretion of plasma growth hormone in subjects of pediatric age]. Rigillo N; Dammacco F; Pentasuglia N; Zimbalatti F Minerva Pediatr; 1975 Apr; 27(15):908-14. PubMed ID: 1134455 [No Abstract] [Full Text] [Related]
70. [Growth hormone secretion in patients with various types of diabetes mellitus and in healthy persons after L-dopa stimulation]. Muszyński J Pol Arch Med Wewn; 1983; 69(4-5):341-50. PubMed ID: 6634455 [No Abstract] [Full Text] [Related]
71. [Growth hormone secretion following metopirone administration]. Szybiński Z; Sieradzki J; Korzeniowska D Pol Arch Med Wewn; 1975 Jun; 53(6):597-604. PubMed ID: 1138250 [No Abstract] [Full Text] [Related]
72. [Growth hormone secretion after oral administration of L-dopa in primary hypothyroidism]. Gembicki M; Sobieszczyk S; Kosowicz J Endokrynol Pol; 1979; 30(2):155-61. PubMed ID: 467382 [No Abstract] [Full Text] [Related]
73. [Secretion of growth hormone in obese subjects on starvation diet]. Zahorska-Markiewicz B; Kokot F; Kuska J Pol Arch Med Wewn; 1974 Dec; 52(6):581-8. PubMed ID: 4438129 [No Abstract] [Full Text] [Related]
74. [Growth hormone secretion induced by L-Dopa and a dopa decarboxylase inhibitor blocked by free fatty acids]. Casanueva F; Villanueva L; Peñalva A; Barrionuevo JA; Vila T; Cabezas-Cerrato J Rev Clin Esp; 1979 May; 153(3):221-4. PubMed ID: 482695 [No Abstract] [Full Text] [Related]
75. [Amantadine potentiation of G.H. relase evoked by L-dopa and its inhibition by nonesterified fatty acids]. Cabezas-Cerrato J; Casanueva Freijo F; Villanueva Aranguren L; Avila C; Fernández-Cruz A Rev Clin Esp; 1977 May; 145(3):165-8. PubMed ID: 866739 [No Abstract] [Full Text] [Related]
76. Reduced growth hormone response to L-dopa and pyridostigmine in obesity. Lee EJ; Kim KR; Lee KM; Lim SK; Lee HC; Lee JH; Lee DJ; Huh KB Int J Obes Relat Metab Disord; 1994 Jul; 18(7):465-8. PubMed ID: 7920871 [TBL] [Abstract][Full Text] [Related]